A measles virus Schwarz vaccine strain (MeVac) vector encoding an IL-15 superagonist increased NK infiltration into tumours in vivo, and MeVac expression of an IL-12 fusion protein was found to promote immune activation and anti-tumour effects[104]. This evidence concerns the gene IL15 and neoplasm.